Novartis India balance sheet

As of Mar 2025

Total assets: ₹948cr+2.5% on Mar 2024
Shareholders' equity: ₹785cr+5.4% on Mar 2024
Total debt: ₹0.0cr−100.0% on Mar 2024
Cash and investments: ₹52.1cr+15.8% on Mar 2024

₹ crore except per share

Tap a line for its trend	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Non-current assets
	1.0	1.7	19.3
	1.1	—	2.5
	15.5	15.4	15.8
	—	—	89.1
	202	—	306
Current assets
	41.1	44.9	54.7
	40.1	41.5	36.2
	52.1	45.0	19.4
	—	551	537
	0.9	2.2	13.9
	—	640	606
	15.6	16.0	16.6
	746	699	677
	948	925	983
Equity
	12.3	12.3	12.3
	773	732	763
	785	—	776
	785	745	776
Liabilities
	0.2	—	7.8
	17.4	—	22.6
	20.8	—	47.8
	0.0	1.4	—
	51.5	61.6	59.7
	—	0.2	30.1
	52.3	17.6	55.7
	13.4	7.5	6.1
	3.4	5.0	3.8
	142	157	159
	163	—	207
	948	925	983

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

NOVARTIND₹1,821.40

Novartis India Limited

· Pharma & Health

₹ CrorePeersBPLPHARMA JENBURPH KPL MAKERSL PARNAXLAB SGRL SHUKRAPHAR SUNLOC

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025
Non-current Assets
+ Property, Plant & Equipment	19.3	1.7	1.0
+ Other Non-current Financial Assets	2.5	—	1.1
+ Deferred Tax Assets	15.8	15.4	15.5
+ Other Non-current Assets	89.1	—	—
Total Non-current Assets	305.6	—	202.0
Current Assets
+ Inventories	54.7	44.9	41.1
+ Trade Receivables	36.2	41.5	40.1
+ Cash & Cash Equivalents	19.4	45.0	52.1
+ Other Bank Balances	536.5	551.1	—
+ Other Current Financial Assets	13.9	2.2	0.9
Current Financial Assets	606.0	639.7	—
+ Other Current Assets	16.6	16.0	15.6
Total Current Assets	677.3	699.3	745.8
Total Assets	982.9	924.9	947.8
Equity
+ Equity Share Capital	12.3	12.3	12.3
+ Other Equity / Reserves	763.3	732.5	772.6
Equity — Owners of Parent	775.7	—	785.0
Total Equity	775.7	744.8	785.0
Liabilities
+ Other Non-current Financial Liab	7.8	—	0.2
+ Provisions — Non-current	22.6	—	17.4
Non-current Liabilities	47.8	—	20.8
+ Borrowings — Current	—	1.4	0.0
+ Trade Payables	59.7	61.6	51.5
+ Other Current Financial Liab	30.1	0.2	—
+ Provisions — Current	55.7	17.6	52.3
+ Current Tax Liabilities	6.1	7.5	13.4
+ Other Current Liabilities	3.8	5.0	3.4
Current Liabilities	159.5	157.2	142.1
Total Liabilities	207.3	—	162.9
Total Equity & Liabilities	982.9	924.9	947.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.